Overjet vs. Pearl: Which Dental AI Platform Actually Fits Your Practice?

Overjet and Pearl are the two names that come up in almost every diagnostic AI conversation. Both are FDA-cleared, both work in real time, and both have strong install bases. But they're not interchangeable — and the practices that treat them as equivalent and just pick the cheaper one are often buying the wrong tool for their actual problem.

Here's how they actually differ.

What Each Platform Is Actually Built For

Pearl is a detection-first platform. Its Second Opinion product is FDA-cleared to flag caries, bone loss, calculus, periapical pathology, and several other findings across both 2D bitewings and periapicals — with recent CBCT expansion adding 3D segmentation. The core proposition is clinical accuracy: surfacing findings the eye might miss or the documentation might understate. Pearl's Practice Intelligence layer adds analytics on top — tracking pathology rates, case acceptance, and production by provider — but the foundation is diagnostic completeness.

Overjet started as a periodontal measurement tool and has since accumulated multiple separate 510(k) clearances — bone level quantification, caries detection, charting assist, and most recently a broader anatomy and restorative detection clearance. The important distinction: Overjet has made meaningful investments in billing and payer-side infrastructure. Its payer integrations — Delta Dental being the most visible — allow AI-detected findings to feed directly into claims validation workflows. For practices worried about audit risk or looking to document clinical rationale for higher-complexity codes, Overjet's architecture is purpose-built for that use case.

The Regulatory Difference That Actually Matters

Both have FDA 510(k) clearances, but the structure differs. Overjet holds multiple separate clearances, each authorizing a specific function with its own indicated use statement. Pearl holds a single primary clearance covering multiple pathology types. Neither approach is better — they represent different regulatory strategies — but the implication is practical: Overjet's modular clearance structure means you can audit exactly what the AI is and isn't authorized to do for each function. That granularity matters if you're in a payer contract that references AI-assisted documentation.

Where Each Platform Wins

Pearl wins if your priority is detection breadth and clinical workflow. The CBCT integration is genuinely ahead of the market. If you're running a practice where comprehensive diagnosis is the bottleneck — missed findings, low case acceptance on multi-surface restorations, inconsistent documentation across providers — Pearl's detection layer and analytics stack will move those numbers.

Overjet wins if your priority is billing defensibility and payer alignment. The payer integration infrastructure is the differentiator here. If you're a DSO negotiating payer contracts, or a practice in a market where Delta Dental is a major payer, Overjet's ability to tie AI-detected findings to claims documentation is a structural advantage Pearl doesn't currently match.

Pricing and Implementation Reality

Both platforms run in the $300–600/month range for single-location practices, with DSO enterprise pricing negotiated separately. Overjet tends to come in at the higher end and often requires direct sales engagement. Pearl has moved toward more self-service onboarding at the practice level, which reduces implementation friction.

PMS compatibility is worth checking before you commit to either. Both integrate with the major systems — Dentrix, Eaglesoft, Open Dental — but the depth of integration varies. Pearl's image acquisition integrations tend to be broader; Overjet's PMS-side charting integrations are deeper. If you're running a less common PMS or a multi-system DSO environment, get a specific integration confirmation in writing before signing.

The Bottom Line

If you're a single-location practice focused on improving diagnostic thoroughness and case acceptance, Pearl is the more direct path to that outcome. If you're a DSO or a billing-conscious practice looking to tie AI documentation to payer workflows and claims defensibility, Overjet's infrastructure is built for that problem.

The mistake most practices make is evaluating these tools on feature lists. The right question isn't which one detects more — both detect well. The question is: what operational outcome are you actually trying to drive, and which platform's architecture is built around that outcome.